NCT01688960 2015-03-17Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid MalignanciesRegeneron PharmaceuticalsPhase 1 Completed48 enrolled